💨 Abstract

BD Life Sciences-Biosciences, a segment of BD, organized a 2-day workshop at CMC Vellore to discuss the assessment of Minimal Residual Disease (MRD) in Acute Leukemia & Myeloma. The workshop focused on technical and analytical components of MRD assessment, attended by 75 participants from India, Philippines, and Australia.

Courtesy: theprint.in

Summarized by Einstein Beta 🤖